Lauren Macdonald shares her testimony at the PsyPal launch event. Witness her personal journey from cancer patient to advocate for psilocybin therapy.
Maryam took part in a Compass Pathways phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression. The testimonial was made during the MEP Action Group for the Medical Use of Psychedelics meeting "Innovating Mental Health in the EU Pharma Legislation.
Clinical Trial participant on AWAKN’s Phase IIa study examining MDMA psychotherapy for Alcohol Use Disorder.